Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers

Colloids and Surfaces B: Biointerfaces

Volumn 115, Issue , 2014, Pages 125-131

  Liu, Liang ^a,b   Tang, Yuhan ^a   Gao, Chao ^a   Li, Yanyan ^a   Chen, Shaodan ^a   Xiong, Ting ^a   Li, Juan ^a   Du, Min ^a   Gong, Zhiyong ^b   Chen, Hong ^c   Yao, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN POLYTECHNIC UNIVERSITY   (China)

^c INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Biodistribution; Cationic nanostructured lipid carriers; Quercetin

Indexed keywords

BIOLOGICAL ORGANS; EMULSIFICATION; HYDROPHOBICITY; PARTICLE SIZE; PHENOLS; TEMPERATURE; TISSUE;

AVERAGE PARTICLE SIZE; BIODISTRIBUTIONS; ENTRAPMENT EFFICIENCY; FUNCTIONAL COMPONENTS; FUNCTIONAL INGREDIENT; NANOSTRUCTURED LIPID CARRIERS; QUERCETIN; TISSUE CONCENTRATIONS;

FLAVONOIDS;

CATIONIC NANOSTRUCTURED LIPID CARRIER; NANOCARRIER; QUERCETIN; UNCLASSIFIED DRUG; CATION; DRUG CARRIER; LIPID; NANOMATERIAL; SOLUTION AND SOLUBILITY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG RELEASE; DRUG TISSUE LEVEL; EMULSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH TEMPERATURE; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LOW TEMPERATURE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL PARAMETERS; POLYDISPERSITY INDEX; PRIORITY JOURNAL; SOLID; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; ZETA POTENTIAL; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; MALE; ORAL DRUG ADMINISTRATION; SOLUTION AND SOLUBILITY; TIME; ULTRASTRUCTURE;

ADMINISTRATION, ORAL; ANIMALS; CATIONS; DRUG CARRIERS; LIPIDS; MALE; MICE; MICE, INBRED C57BL; NANOSTRUCTURES; PARTICLE SIZE; QUERCETIN; SOLUTIONS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 84890302985     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.11.029     Document Type: Article

References (53)

1. Askari G., Ghiasvand R., Paknahad Z., Karimian J., Rabiee K., Sharifirad G., Feizi A. The effects of quercetin supplementation on body composition, exercise performance and muscle damage indices in athletes. Int. J. Prev. Med. 2013, 4:21-26.
2. Date A.A., Nagarsenker M.S., Patere S., Dhawan V., Gude R.P., Hassan P.A., Aswal V., Steiniger F., Thamm J., Fahr A. Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration. Mol. Pharm. 2011, 8:716-726.
3. Ekstrom A.M., Serafini M., Nyren O., Wolk A., Bosetti C., Bellocco R. Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden. Ann. Oncol. 2011, 22:438-443.
4. Cui Y., Morgenstern H., Greenland S., Tashkin D.P., Mao J.T., Cai L., Cozen W., Mack T.M., Lu Q.Y., Zhang Z.F. Dietary flavonoid intake and lung cancer - a population-based case-control study. Cancer 2008, 112:2241-2248.
5. Ruiz M.J., Fernandez M., Pico Y., Manes J., Asensi M., Carda C., Asensio G., Estrela J.M. Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J. Agric. Food Chem. 2009, 57:3180-3186.
6. Utesch D., Feige K., Dasenbrock J., Broschard T.H., Harwood M., Danielewska-Nikiel B., Lines T.C. Evaluation of the potential in vivo genotoxicity of quercetin. Mutat. Res. 2008, 654:38-44.
7. Harwood M., Danielewska-Nikiel B., Borzelleca J.F., Flamm G.W., Williams G.M., Lines T.C. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 2007, 45:2179-2205.
8. Chen X., Yin O.Q., Zuo Z., Chow M.S. Pharmacokinetics and modeling of quercetin and metabolites. Pharm. Res. 2005, 22:892-901.
9. de Boer V.C., Dihal A.A., van der Woude H., Arts I.C., Wolffram S., Alink G.M., Rietjens I.M., Keijer J., Hollman P.C. Tissue distribution of quercetin in rats and pigs. J. Nutr. 2005, 135:1718-1725.
10. Graefe E.U., Wittig J., Mueller S., Riethling A.K., Uehleke B., Drewelow B., Pforte H., Jacobasch G., Derendorf H., Veit M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol. 2001, 41:492-499.
11. Khaled K.A., El-Sayed Y.M., Al-Hadiya B.M. Disposition of the flavonoid quercetin in rats after single intravenous and oral doses. Drug Dev. Ind. Pharm. 2003, 29:397-403.
12. Hollman P.C., Vd Gaag M., Mengelers M.J., van Trijp J.M., de Vries J.H., Katan M.B. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic. Biol. Med. 1996, 21:703-707.
13. Gugler R., Leschik M., Dengler H.J. Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol. 1975, 9:229-234.
14. Pool H., Mendoza S., Xiao H., McClements D.J. Encapsulation and release of hydrophobic bioactive components in nanoemulsion-based delivery systems: impact of physical form on quercetin bioaccessibility. Food Funct. 2013, 4:162-174.
15. Silva L.F.C., Kasten G., de Campos C.E.M., Chinelatto A.L., Lemos-Senna E. Preparation and characterization of quercetin-loaded solid lipid microparticles for pulmonary delivery. Powder Technol. 2013, 239:183-192.
16. Bose S., Michniak-Kohn B. Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. Eur. J. Pharm. Sci. 2012, 48:442-452.
17. Gang W., Jie W.J., Ping Z.L., Ming Du S., Ying L.J., Lei W., Fang Y. Liposomal quercetin: evaluating drug delivery in vitro and biodistribution in vivo. Expert Opin. Drug Deliv. 2012, 9:599-613.
18. Vicentini F.T., Vaz M.M., Fonseca Y.M., Bentley M.V., Fonseca M.J. Characterization and stability study of a water-in-oil microemulsion incorporating quercetin. Drug Dev. Ind. Pharm. 2011, 37:47-55.
19. Li H., Zhao X., Ma Y., Zhai G., Li L., Lou H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release 2009, 133:238-244.
20. Gao L., Liu G., Wang X., Liu F., Xu Y., Ma J. Preparation of a chemically stable quercetin formulation using nanosuspension technology. Int. J. Pharm. 2011, 404:231-237.
21. Sun M., Gao Y., Pei Y., Guo C., Li H., Cao F., Yu A., Zhai G. Development of nanosuspension formulation for oral delivery of quercetin. J. Biomed. Nanotechnol. 2010, 6:325-332.
22. Singh D., Rawat M.S., Semalty A., Semalty M. Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery. Curr. Drug Discov. Technol. 2012, 9:17-24.
23. Landi-Librandi A.P., Chrysostomo T.N., Caleiro Seixas Azzolini A.E., Marzocchi-Machado C.M., de Oliveira C.A., Lucisano-Valim Y.M. Study of quercetin-loaded liposomes as potential drug carriers: in vitro evaluation of human complement activation. J. Liposome Res. 2012, 22:89-99.
24. Wong M.Y., Chiu G.N.C. Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model. Nanomed.-Nanotechnol. Biol. Med. 2011, 7:834-840.
25. Dhawan S., Kapil R., Singh B. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. J. Pharm. Pharmacol. 2011, 63:342-351.
26. Fang R., Hao R., Wu X., Li Q., Leng X., Jing H. Bovine serum albumin nanoparticle promotes the stability of quercetin in simulated intestinal fluid. J. Agric. Food Chem. 2011, 59:6292-6298.
27. Fang R., Jing H., Chai Z., Zhao G., Stoll S., Ren F., Liu F., Leng X. Design and characterization of protein-quercetin bioactive nanoparticles. J Nanobiotechnol. 2011, 9:19.
28. Khachane P., Date A.A., Nagarsenker M.S. Positively charged polymeric nanoparticles: application in improving therapeutic efficacy of meloxicam after oral administration. Pharmazie 2011, 66:334-338.
29. Kumari A., Yadav S.K., Pakade Y.B., Singh B., Yadav S.C. Development of biodegradable nanoparticles for delivery of quercetin. Colloids Surf. B Biointerfaces 2010, 80:184-192.
30. Chen-yu G., Chun-fen Y., Qi-lu L., Qi T., Yan-wei X., Wei-na L., Guang-xi Z. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int. J. Pharm. 2012, 430:292-298.
31. Sun M., Nie S., Pan X., Zhang R., Fan Z., Wang S. Quercetin-nanostructured lipid carriers: characteristics and anti-breast cancer activities in vitro. Colloids Surf. B Biointerfaces 2013, 113C:15-24.
32. Tan Q., Liu W., Guo C., Zhai G. Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery. Int. J. Nanomed. 2011, 6:1621-1630.
33. Kitagawa S., Tanaka Y., Tanaka M., Endo K., Yoshii A. Enhanced skin delivery of quercetin by microemulsion. J. Pharm. Pharmacol. 2009, 61:855-860.
34. Vicentini F.T., Simi T.R., Del Ciampo J.O., Wolga N.O., Pitol D.L., Iyomasa M.M., Bentley M.V., Fonseca M.J. Quercetin in w/o microemulsion: in vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo. Eur. J. Pharm. Biopharm. 2008, 69:948-957.
35. Singhal A., Jain H., Singhal V., Elias E.J., Showkat A. Colon-targeted quercetin delivery using natural polymer to enhance its bioavailability. Pharmacognosy Res. 2011, 3:35-39.
36. Plapied L., Duhem N.,Rieux A., Preat V. Fate of polymeric nanocarriers for oral drug delivery. Curr. Opin. Colloid. In. 2011, 16:228-237.
37. Kuo Y.C., Wang C.C. Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia. Colloids Surf. B Biointerfaces 2013, 101:101-105.
38. Date A.A., Srivastava D., Nagarsenker M.S., Mulherkar R., Panicker L., Aswal V., Hassan P.A., Steiniger F., Thamm J., Fahr A. Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, characterization and evaluation. Nanomedicine (Lond.) 2011, 6:1309-1325.
39. Jia L., Zhang D., Li Z., Duan C., Wang Y., Feng F., Wang F., Liu Y., Zhang Q. Nanostructured lipid carriers for parenteral delivery of silybin: biodistribution and pharmacokinetic studies. Colloids Surf. B Biointerfaces 2010, 80:213-218.
40. Liu D., Liu Z., Wang L., Zhang C., Zhang N. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf. B Biointerfaces 2011, 85:262-269.
41. Bieger J., Cermak R., Blank R., de Boer V.C., Hollman P.C., Kamphues J., Wolffram S. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J. Nutr. 2008, 138:1417-1420.
42. Frohlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomed. 2012, 7:5577-5591.
43. Xiao K., Li Y., Luo J., Lee J.S., Xiao W., Gonik A.M., Agarwal R.G., Lam K.S. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 2011, 32:3435-3446.
44. He C., Hu Y., Yin L., Tang C., Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 2010, 31:3657-3666.
45. Tamjidi F., Shahedi M., Varshosaz J., Nasirpour A. Nanostructured lipid carriers (NLC): a potential delivery system for bioactive food molecules. Innovative Food Sci. Emerg. Technol. 2013, 19:29-43.
46. Dev S., Prabhakaran P., Filgueira L., Iyer K.S., Raston C.L. Microfluidic fabrication of cationic curcumin nanoparticles as an anti-cancer agent. Nanoscale 2012, 4:2575-2579.
47. Youshia J., Kamel A.O., El Shamy A., Mansour S. Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide. Int. J. Nanomed. 2012, 7:2483-2496.
48. Kong W.H., Park K., Lee M.Y., Lee H., Sung D.K., Hahn S.K. Cationic solid lipid nanoparticles derived from apolipoprotein-free LDLs for target specific systemic treatment of liver fibrosis. Biomaterials 2013, 34:542-551.
49. Renugadevi J., Prabu S.M. Quercetin protects against oxidative stress-related renal dysfunction by cadmium in rats. Exp. Toxicol. Pathol. 2010, 62:471-481.
50. Lai P.B., Zhang L., Yang L.Y. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-beta1 and connective tissue growth factor in streptozotocin-induced diabetic rats. Ren. Fail. 2012, 34:83-87.
51. Sanchez-Gonzalez P.D., Lopez-Hernandez F.J., Perez-Barriocanal F., Morales A.I., Lopez-Novoa J.M. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumor activity. Nephrol. Dial. Transplant. 2011, 26:3484-3495.
52. Liu C.M., Sun Y.Z., Sun J.M., Ma J.Q., Cheng C. Protective role of quercetin against lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKs and NF-kappaB pathway. Biochim. Biophys. Acta 2012, 1820:1693-1703.
53. Ishisaka A., Ichikawa S., Sakakibara H., Piskula M.K., Nakamura T., Kato Y., Ito M., Miyamoto K., Tsuji A., Kawai Y., Terao J. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic. Biol. Med. 2011, 51:1329-1336.